GB1496671A - Anti-cancer-active sour milk fraction - Google Patents

Anti-cancer-active sour milk fraction

Info

Publication number
GB1496671A
GB1496671A GB1383874A GB1383874A GB1496671A GB 1496671 A GB1496671 A GB 1496671A GB 1383874 A GB1383874 A GB 1383874A GB 1383874 A GB1383874 A GB 1383874A GB 1496671 A GB1496671 A GB 1496671A
Authority
GB
United Kingdom
Prior art keywords
milk
molecular weight
molecules
march
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1383874A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grindstedvaerket AS
Original Assignee
Grindstedvaerket AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindstedvaerket AS filed Critical Grindstedvaerket AS
Priority to GB1383874A priority Critical patent/GB1496671A/en
Publication of GB1496671A publication Critical patent/GB1496671A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1496671 Anticancer product from soured milk GRINDSTEDVAERKET AS 27 March 1975 [28 March 1974] 13838/74 Heading A5B An anticancer composition comprises (a) a fraction of the casein part of soured mammalian milk containing molecules having a molecular weight greater than 500 (as measured by their ability to be stopped by a membrane rejecting molecules having a molecular weight greater than 500) and below 20,000 (as measured by their ability to pass a membrane rejecting molecules having a molecular weight of 20,000 and above), (b) sterile water and optionally (c) up to 60 weight % of other pharmaceutical adjuvants. The sour milk may be prepared from the milk or cream of cows, goats, sheep, horses, donkeys or buffalos either by allowing it to stand or by accelerating souring by the addition of bacteria, e.g. Thermobacteria helvetium, Streptococcus thermophiles or diplococci. The fat may be removed before fractionation leaving the casein part only. This may be sterilized before or after fractionation, e.g. by irradiation. The casein part may be fractionated by ultrafiltration using cellulose acetate filters or separation on molecular sieves. The aqueous product may be freezedried, and dispersed in sterile pyrogen-free water for use.
GB1383874A 1975-03-27 1975-03-27 Anti-cancer-active sour milk fraction Expired GB1496671A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1383874A GB1496671A (en) 1975-03-27 1975-03-27 Anti-cancer-active sour milk fraction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1383874A GB1496671A (en) 1975-03-27 1975-03-27 Anti-cancer-active sour milk fraction

Publications (1)

Publication Number Publication Date
GB1496671A true GB1496671A (en) 1977-12-30

Family

ID=10030284

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1383874A Expired GB1496671A (en) 1975-03-27 1975-03-27 Anti-cancer-active sour milk fraction

Country Status (1)

Country Link
GB (1) GB1496671A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113396A2 (en) * 1983-01-11 1984-07-18 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
DE3622968A1 (en) * 1986-07-09 1988-02-04 Lehmacher & Sohn Masch Process and device for the continuous production of packaging bags
WO1991006308A1 (en) * 1989-10-30 1991-05-16 Bengt Andersson A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract
WO1995001100A1 (en) * 1993-07-02 1995-01-12 Ballestra Francois Process for the preservation of ass's milk and applications
EP1151754A1 (en) * 2000-05-05 2001-11-07 François Ballestra Use of a equine milk fraction for the inhibition of interleukin-1 production

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113396A2 (en) * 1983-01-11 1984-07-18 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
EP0113396A3 (en) * 1983-01-11 1985-11-21 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
DE3622968A1 (en) * 1986-07-09 1988-02-04 Lehmacher & Sohn Masch Process and device for the continuous production of packaging bags
WO1991006308A1 (en) * 1989-10-30 1991-05-16 Bengt Andersson A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract
WO1995001100A1 (en) * 1993-07-02 1995-01-12 Ballestra Francois Process for the preservation of ass's milk and applications
FR2707877A1 (en) * 1993-07-02 1995-01-27 Ballestra Francois Method of preserving donkey milk and its therapeutic and cosmetological applications.
EP1151754A1 (en) * 2000-05-05 2001-11-07 François Ballestra Use of a equine milk fraction for the inhibition of interleukin-1 production
FR2808444A1 (en) * 2000-05-05 2001-11-09 Francois Ballestra USE OF A FRACTION OF EQUINE MILK FOR THE MANUFACTURE OF A COMPOSITION HAVING AN ACTIVITY OF INHIBITION OF THE PRODUCTION OF INTERLEUKIN-1 AND THE COMPOSITION THUS OBTAINED

Similar Documents

Publication Publication Date Title
Melish et al. The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin
Jones et al. The bacterial growth inhibitor (lactenin) of milk: i. the preparation in concentrated form
US5935632A (en) Method for producing consumer milk with good keeping qualities
EP0372501A3 (en) Synthetic antigens, method for their preparation and their use
ES8201006A1 (en) Product enriched by alpha-lactalbumine, its production starting from lactoserum and applications of this product.
JP2805490B2 (en) Bacterial toxin neutralizer
GB1496671A (en) Anti-cancer-active sour milk fraction
DE69032646T2 (en) A CASEIN FACTION FOR THERAPEUTIC PREVENTIVE AND / OR DIAGNOSTIC USE IN RESPIRATORY INFECTION
Bennett et al. Serological Reactivity and ln Vivo Toxicity of Staphylococcus aureus Enterotoxins A and D in Selected Canned Foods
Isogai et al. Effects of leptospiral lipopolysaccharide on rabbit platelets
Davies et al. Recent developments in yoghurt starters: the use of milk concentrated by reverse osmosis for the manufacture of yoghurt
ES394715A1 (en) Preparation of cheese
Twardock et al. The state of calcium and strontium in goat's milk
GB1362502A (en) Process for the production of dry milk protein products
Jolivet-Reynaud et al. Selective cytotoxicity of Clostridium perfringens delta toxin on rabbit leukocytes
GB1413049A (en) Cheese manufacture
GB1295872A (en)
Domingue et al. Inhibition by lipopolysaccharide of immune phagocytosis of latex particles modified with common antigen of enteric bacteria.
DE69927259T2 (en) PROCESS FOR THE PRODUCTION OF SUESSEM FRESH CAESE
Lintner et al. Somatic cell reference samples for calibration of milk somatic cell counting methods
GB1403086A (en) Treatment of whey protein
EP0009464A1 (en) Foam bath composition
GB374402A (en) The manufacture of lactoserum and of products therefrom
Turner Studies on soft curd milk prepared by the enzyme treatment method
AT228399B (en) Process for the preparation of a culture medium for the production of nisin

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee